Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

EORTC Groups Annual Meeting (EGAM) 2019 /
Assessing quality of life in clinical trials

14th - 15th Mar 2019

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 21.03.19
Views: 901
Rating:

Prof Mogens Grønvold - University of Copenhagen, Copenhagen, Denmark

Prof Mogens Grønvold speaks to ecancer at the 2019 EORTC Groups Annual Meeting (EGAM) about how different treatments administered in a clinical trial setting can impact the patient and their experience.

Prof Grønvold describes the questionnaire used to measure the quality of life of these patients and noted its flexibility in combining them with item lists.

He also explains the impact that these assessments can inflict on the clinical trial and how these findings may influence the regulation of cancer care.

 

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation